Clinical Trials with Fenbendazole and Oxibendazole for Strongyloides westeri Infection in Foals
Open Access
- 1 March 1981
- journal article
- research article
- Published by American Veterinary Medical Association (AVMA) in American Journal of Veterinary Research
- Vol. 42 (3) , 526-527
- https://doi.org/10.2460/ajvr.1981.42.03.526
Abstract
SUMMARY: In 2 trials, treatment with fenbendazole (50 mg/kg of body weight by stomach tube) resulted in reductions of Strongyloides westeri worm egg counts by averages of 86% and > 99%, respectively, and in complete clearance of eggs from feces of 9 of 12 foals that were positive before treatment. In 6 trials, treatment with oxibendazole (10 mg/kg of body weight intraorally) resulted in 100% reduction of strongyloides worm egg counts in 5 trials and 81% in 1 trial; clearance of S westeri eggs from feces was recorded for 31 of 33 foals that were positive before treatment.This publication has 3 references indexed in Scilit:
- CRITICAL TESTS AND CLINICAL-TRIALS ON OXIBENDAZOLE IN HORSES WITH SPECIAL REFERENCE TO REMOVAL OF PARASCARIS-EQUORUM1979
- OBSERVATIONS ON DEVELOPMENT OF STRONGYLOIDES-WESTERI IN FOALS NURSING DAMS TREATED WITH CAMBENDAZOLE OR THIABENDAZOLE1977
- CRITICAL TESTS WITH OXIBENDAZOLE AGAINST GASTROINTESTINAL PARASITES OF PONIES1976